王志华, 张文嫦, 黄洁怡, 伦健炽, 丁倚晴, 吕伟杰, 徐霄龙, 郭世宁. 基于蛋白质芯片技术探究大黄酸通过精氨酸代谢抑制结直肠癌机制J. 药学学报, 2022, 57(8): 2378-2387. DOI: 10.16438/j.0513-4870.2022-0065
引用本文: 王志华, 张文嫦, 黄洁怡, 伦健炽, 丁倚晴, 吕伟杰, 徐霄龙, 郭世宁. 基于蛋白质芯片技术探究大黄酸通过精氨酸代谢抑制结直肠癌机制J. 药学学报, 2022, 57(8): 2378-2387. DOI: 10.16438/j.0513-4870.2022-0065
WANG Zhi-hua, ZHANG Wen-chang, HUANG Jie-yi, LUN Jian-chi, DING Yi-qing, LÜ Wei-jie, XU Xiao-long, GUO Shi-ning. Mechanism of rhein inhibition of colorectal cancer through arginine metabolism based on protein chipJ. Acta Pharmaceutica Sinica, 2022, 57(8): 2378-2387. DOI: 10.16438/j.0513-4870.2022-0065
Citation: WANG Zhi-hua, ZHANG Wen-chang, HUANG Jie-yi, LUN Jian-chi, DING Yi-qing, LÜ Wei-jie, XU Xiao-long, GUO Shi-ning. Mechanism of rhein inhibition of colorectal cancer through arginine metabolism based on protein chipJ. Acta Pharmaceutica Sinica, 2022, 57(8): 2378-2387. DOI: 10.16438/j.0513-4870.2022-0065

基于蛋白质芯片技术探究大黄酸通过精氨酸代谢抑制结直肠癌机制

Mechanism of rhein inhibition of colorectal cancer through arginine metabolism based on protein chip

  • 摘要: 大黄酸是从大黄、芦荟、何首乌等中提取的一种蒽醌类化合物, 本研究通过蛋白质芯片技术筛选大黄酸潜在作用靶点, 并探究其抑制结直肠癌的潜在机制。采用集落形成实验和划痕实验分别检测大黄酸对人HCT116细胞系增殖和迁移能力影响; 利用蛋白质芯片技术筛选大黄酸靶向蛋白, 对大黄酸特异性结合蛋白进行KEGG和蛋白互作分析; 利用qRT-PCR和Western blot技术检测大黄酸对HCT116细胞中B淋巴细胞瘤-2基因相关X蛋白(BCL-2-associated X protein, BAX)、B淋巴细胞瘤-2基因(B-cell lymphoma-2, BCL-2) 和精氨基琥珀酸合成酶1 (argininosuccinate synthetase 1, ASS1) 表达水平影响; 并通过氧化偶氮甲烷与葡聚糖硫酸钠(azoxymethane and dextran sodium sulfate, AOM/DSS) 联合诱导的结直肠癌模型小鼠验证大黄酸的体内抗肿瘤效果, 实验动物操作均按照动物福利和华南农业大学实验动物伦理委员会标准执行, 并得到伦理委员会的批准。结果表明, 大黄酸特异性结合蛋白主要参与氨基酸合成代谢, 尤其是精氨酸合成代谢信号通路; 并以浓度依赖性抑制HCT116细胞增殖和迁移。大黄酸作用HCT116细胞24 h后, 显著增强BAX和ASS1表达, 以及细胞一氧化氮水平; 在结直肠癌小鼠模型中, 大黄酸显著缓解AOM/DSS诱导的体重下降, 降低便隐血评分, 增强结肠肿瘤组织中BAX和ASS1的表达, 并提高血清中精氨酸和一氧化氮含量; IHC和HE染色表明, 大黄酸减轻AOM/DSS诱导的结直肠癌小鼠结肠组织中Ki67表达及巨噬细胞浸润, 延缓肿瘤形成。综上, 大黄酸可通过精氨酸关键限速酶ASS1, 调节精氨酸和NO代谢, 从而发挥抗肿瘤活性。

     

    Abstract: Rhein is an anthraquinone compound extracted from rhubarb, aloe vera, Polygonum multiflorum. In this study, we screened the potential targets of rhein through protein chip technology and investigated the underlying mechanism of its inhibition of colorectal cancer. Colony formation assay and scratch assay were used to examine the effect of rhein on the proliferation and migration abilities of HCT116 cell; KEGG and protein interaction analyses of rhein specific binding proteins by screening rhein binding proteins using protein chip; qRT-PCR and Western blot assays were used to determine the effect of rhein on the expression levels of BCL-2-associated X protein (BAX), B-cell lymphoma-2 (BCL-2) and argininosuccinate synthetase 1 (ASS1) in HCT116 cell. The antitumor effect of rhein was verified by azoxymethane combined with dextran sodium sulfate (AOM/DSS) induced colorectal cancer model. Experimental animal procedures were performed in accordance with animal welfare and the standards of the Laboratory Animal Ethics Committee of South China Agricultural University, with approval from the ethics committee. In vivo and in vitro results indicate that rhein specific binding proteins are mainly involved in amino acid anabolism, especially the arginine anabolic signaling pathway. Rhein inhibited the proliferation and migration of HCT116 cell in a concentration-dependent manner. Treated with rhein for 24 h significantly enhanced the expression of BAX and ASS1 in HCT116 cells, as well as the level of nitric oxide (NO) metabolism. In a mouse model of colorectal cancer, rhein significantly alleviated AOM/DSS induced weight loss and reduced fecal occult blood score. Meanwhile, rhein enhanced BAX and ASS1 expression in colon tumor tissue, as well as increased arginine and NO in serum. IHC and HE stain indicated that rhein alleviated Ki67 expression and macrophage infiltration in the colonic tissue of mice with AOM/DSS and delayed tumor formation. In conclusion, rhein can exert antitumor activity by regulating arginine and NO metabolism through ASS1.

     

/

返回文章
返回